Cell Therapy Manufacturing Market to Hit USD 16,400 Million by 2032
Ottawa, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The global cell therapy manufacturing market revenue is projected to surpass around USD 9,640 million by 2029, a...
Rentschler, CGT Catapult, and Refeyn Sign AAV Gene Therapy Agreement
Rentschler Biopharma agreed to collaborate with Cell and Gene Therapy Catapult and Refeyn to develop and apply novel process analytical technologies (PAT) to improve the...
Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), has today announced a collaborative partnership...
Cell and Gene Therapy Scale-Up Challenges
Cell and gene therapy developers looking to move to commercial manufacture should embrace innovative systems, says new U.K.-based technology supplier Cellular Origins. Firms sometimes struggle...